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Between October 2005 and May 2006, a total of 727 badgers found dead in Wales were reported, and 550 were
delivered to the Regional Laboratories of the Veterinary Laboratories Agency (VLA). Of the 459 carcasses
suitable for examination, 55 were deemed to be infected with Mycobacterium bovis on the basis of culture,
spoligotyping, and variable-number tandem repeat typing. Acid-fast bacteria were observed histologically in a
further six badgers, but these bacteria were not confirmed as M. bovis by culture. A rapid serological test
(BrockTB Stat-Pak) performed on thoracic blood showed a sensitivity of 35% and a specificity of 99%. Presence
of M. bovis infection was 45 times more likely to be confirmed postmortem by culture in BrockTB Stat-Pak-
reactive animals than in seronegative ones. Using visible carcass lesions as a marker of bovine tuberculosis
(bTB) infection had a similar sensitivity (38%) but was significantly less specific (84%) than serology. The
overall accuracy of the antibody detection was 93% (346 correct results from 374 tests), whereas the accuracy
of regarding visible lesions as a marker for bTB infection was 78% (354 correct from 453 carcasses examined).
Culture remains the gold standard method for detecting M. bovis infection in badgers. However, where
resources are limited and/or an instant result is preferred, the BrockTB Stat-Pak could be used in field
surveillance efforts to identify animals which should be examined further by only submitting test-negative
animals to more detailed postmortem examination and culture.
Mycobacterium bovis infection is the cause of bovine tuber-
culosis (bTB) in a wide range of mammal species, including
domestic livestock and captive and free-ranging wildlife. Bo-
vine TB remains an important zoonotic disease with significant
impacts on the economy in many countries (6, 22, 23). Eur-
asian badgers (Meles meles) are a wildlife maintenance host of
bTB in Great Britain and Ireland (5, 15) and are implicated in
the maintenance and onward transmission of M. bovis infection
to cattle (10, 19).
Surveillance of wildlife vectors of disease for prevalence
estimates of infection may be valuable in disease control strat-
egies and for the assessment of risk of transmission to live-
stock. Diagnosis of bTB in live badgers has been demonstrated
using assays of both serological (4, 20) and cell-mediated (8, 9)
immunity. While isolation of M. bovis from clinical samples is
definitive, it is too insensitive for badgers, as infected animals
yield positive samples infrequently and intermittently (3). A
rapid serological test (BrockTB Stat-Pak; Chembio Diagnostic
Systems, Inc.) has recently been developed for the diagnosis of
bTB in multiple wildlife species (20). The test has modest
sensitivity (46 to 55%) for antibody detection in live, infected
badgers, but it has the advantages of being simple, rapid, in-
expensive, and suitable for field application. Its utility as an
animal-side test for badgers, however, is limited by the diffi-
culties associated with obtaining a blood sample from a non-
anesthetized animal.
Where carcasses are recovered and submitted for mycobac-
terial culture, the sensitivity of diagnosis depends on the effort
taken for careful examination and on the number of tissue
samples submitted for culture testing and histopathology (7),
as well as on the condition of the carcass. In many cases, the
cost involved may prove prohibitive. Reliance on the presence
of visible lesions as indicative of bTB is fraught with difficulties,
as infected animals may present with no visible lesions or
lesions may be the result of other infections while having the
appearance of bTB (reviewed in reference 13). The purpose of
this study was to determine whether the BrockTB Stat-Pak test
could detect M. bovis antibody in blood collected from the car-
casses of dead badgers as an alternative means of diagnosis and
decision making. Animals were obtained as part of a separate
government-funded study to determine the prevalence of bTB in
badgers found dead in Wales (http://new.wales.gov.uk/depc/
publications/environmentandcountryside/animalhealthandwelfare/
diseasesurveillancecontrol/bovinetb/2567889/publicationindex/
2326585/badgerfounddeadreport?langen). Our results reveal
that the BrockTB Stat-Pak test used on thoracic blood samples
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was very specific (99%) but less sensitive (35%) than found
previously for live badgers (2, 14). However, bTB was 45 times
more likely to be confirmed in BrockTB Stat-Pak-positive an-
imals than in BrockTB Stat-Pak-negative ones, whereas using
visible carcass lesions as a marker of infection was less reliable.
MATERIALS AND METHODS
Examination of found-dead badgers. The public was asked to notify the State
Veterinary Service (now Animal Health) when they saw a dead badger. Badger
carcasses were collected and transported to local Veterinary Laboratories
Agency (VLA) regional laboratories, usually within 24 h of collection, by animal
health officers of the State Veterinary Service. Badgers were deemed unsuitable
for postmortem examination if the carcass was not intact, if the carcass was
distended with gas, if there was severe myiasis, or if the carcass was flattened.
Carcasses were refrigerated at VLA between 2 and 8°C and examined as soon as
possible after receipt and always within 72 h. Postmortem examination was
conducted using a standard protocol as previously described (17). Relevant to
this study, data were also collected on animal sex, weight, and tooth wear, the
latter two measures being used to approximate the ages of the badgers. Cubs
were considered to have tooth wear between 0 and 25% (16) and to weigh less
than 8 kg (based on unpublished analyses of other badgers). The severity of
lesions in each tissue examined was scored subjectively from 0 to 4, with 0
indicating no visible lesions. For confirmation of bTB, an attempt was made to
collect a standard sample of one-half of each of the retropharyngeal and bron-
chial lymph nodes and half of the mediastinal lymph nodes if available (half of
the hepatic lymph node was also collected after 15 March 2006) plus any other
lesions suggestive of bTB into 15 ml of 1% cetylpyridinium chloride (CPC). Any
lesions suggestive of bTB available after this sampling were preserved in 10%
buffered formaldehyde solution. Bite wounds were divided between a separate
container of CPC and 10% buffered formaldehyde solution. The standard sample
and any bite wounds were cultured for mycobacteria, usually the next day, using
the methods of the standard protocol (17) with the exception that 12 slopes,
rather than 6 slopes, of modified Middlebrook 7H11 agar were incubated for 12
weeks rather than 6 weeks. Whenever M. bovis was isolated, its molecular type
(spoligotype and variable-number tandem repeat [VNTR] type) was determined
using published methods (11, 18). In 134 badgers that had visible carcass lesions
or bite wounds and where sufficient tissue was available after sampling for
culture, preserved samples of visible carcass lesions or bite wounds were stained
by the Ziehl-Neelsen method and examined microscopically for acid-fast bacilli
(AFB). For the purposes of this study, only animals in which M. bovis was
isolated by culture were classified as bTB positive.
BrockTB Stat-Pak testing. A simple and rapid antibody detection assay was
developed by Chembio Diagnostic Systems, Inc., using colored latex-based lat-
eral flow technology and a cocktail of selected M. bovis antigens, including
ESAT-6, CFP10, and MPB83 (14). Where possible, a blood sample was collected
for the lateral flow immunoassay, either by using a syringe and 14-gauge needle
from the thorax via the chest wall before the carcass was opened or, if this was
not possible, during the necropsy. The blood sample was collected from the heart
or free from within the thorax. An assessment of the condition of the blood was
made on a scale of 1 to 4, with 1 being fresh with little hemolysis and 4 being
severely hemolysed. Blood samples were tested for the presence of specific
antibody as previously described (21), immediately after collection. Results were
read at 20 min after adding sample buffer. Any visible band in the test area of the
BrockTB Stat-Pak, in addition to the control line, was considered an antibody-
positive result, whereas no band in the test area in addition to the visible control
line was considered a negative result.
Data analyses. Diagnostic performance was evaluated against bTB positivity
(determined by culture and/or histology). The test sensitivity, specificity, and
positive predictive value (PPV) were calculated using GraphPad InStat (version
3.06 for Windows; GraphPad Software, San Diego, CA) and are reported with
95% confidence interval (CI). Tests of significance between proportions (Fisher’s
exact test) or between medians (Mann-Whitney test) and the calculation of odds
ratio were performed using the same software.
RESULTS AND DISCUSSION
Confirmation of bTB infection and its prevalence. Between
26 October 2005 and 31 May 2006, a total of 727 badgers found
dead in Wales were reported, and 550 were delivered to the
Regional Laboratories of the VLA. Of the 459 carcasses that
were sampled, M. bovis was isolated from 55 badgers, for which
spoligotype and VNTR type were determined. Stained tissue
samples from 117 culture-negative badgers revealed a further 6
culture-negative badgers considered likely to be infected with
M. bovis on the basis of AFB being present. However, given
that these could not be confirmed by culture they were dis-
counted from the calculations of sensitivity and specificity, etc.
Mycobacterium avium was isolated from two badgers. No acid-
fast organisms were seen histologically, and no M. bovis was
isolated from either of these animals.
Further details of the geographical distribution and preva-
lence of bTB in Welsh badgers is the subject of another paper
(submitted for publication). Only four distinct molecular types
of bTB were seen in the 55 badgers: spoligotype 17 (with the
unique VNTR type 7555*33.1), spoligotype 22 (with VNTR
type 7524*33.1), and two VNTR types of spoligotype 9. One of
these shares its VNTR type with spoligotype 22, and one had
the unique VNTR type 7555*32.1.
BrockTB Stat-Pak test and/or lesions as diagnostic criteria.
A lateral flow immunoassay based on the detection of serum
antibodies to M. bovis antigens (BrockTB Stat-Pak test; Chem-
bio Diagnostic Systems, Inc.) (14) was evaluated for the first
time using unseparated thoracic blood samples obtained from
animals found dead. The test was originally designed for use
with serum obtained from live animals, where it was demon-
strated to have a sensitivity of 51% (95% CI, 46 to 55%) and
a specificity of 93% (95% CI, 91 to 95%) following validation
on 1,532 badgers against culture postmortem (20). Recently,
the test has been shown to also work with unclotted (freshly
obtained) whole blood or plasma or even diaphragm extract
from white-tailed deer experimentally inoculated with M. bovis
(20). In this study, 379 badgers of the total 459 were examined
by using the BrockTB Stat-Pak (37 samples from infected
badgers, 337 samples from noninfected badgers, and 5 of the 6
badgers for which only histological evidence of infection was
obtained). In some cases it was not possible to obtain blood
from the carcass, and testing by BrockTB Stat-Pak was not
carried out at the end of the study due to test kits being
temporarily unavailable.
The ratio of males to females submitted to postmortem
examination was 3:2 and was no different for the subset tested
with the Stat-Pak (P  0.57, Fisher’s exact test). For all badgers
examined, the median weight was 9.6 kg, the median body
length was 68 cm, and the median tooth wear was 0.5. The
subset of animals tested with the Stat-Pak was representative
of the whole in each respect (P  0.5, Mann-Whitney Test).
Based on the weight and tooth wear data to approximate the
age of the badgers, there were 164 cubs (36%) and 295 adults
(64%) examined. These proportions were the same for the
subset tested by Stat-Pak (P  0.79, Fisher’s exact test).
Blood could be obtained from 226 animals (60%) through
the chest wall before the carcass was opened. In a further 152
cases (40%) this was not possible. Reasons for this were either
that the needle became blocked by a blood clot or thoracic
viscera that had become macerated through trauma or that
there was only a small amount of blood in the heart/thorax. In
these cases the sample was taken during the necropsy. Details
of the procedure used were not recorded in one case. Blood
quality was significantly poorer (P  0.0001, Mann-Whitney
test) if it had to be obtained during necropsy. The median
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score was 3 in the latter case, versus 2 for blood obtained
before the carcass was opened. The sensitivity and specificity of
the BrockTB Stat-Pak were 32% and 99% for blood obtained
before the carcasses was opened and 44% and 99% for blood
obtained at necropsy. However, the sensitivity and specificity of
the BrockTB Stat-Pak were not significantly affected by the
condition of the blood or by the method used to obtain
the sample (Fisher’s exact test) (data not shown). Overall, the
sensitivity for bTB detection was 35% (95% CI, 20 to 53%)
with a specificity of 99% (95% CI, 97 to 100%) (Table 1). The
lower sensitivity of the test when performed postmortem
rather than on live animals can be accounted for by degrada-
tion of immunoglobulins after death. This was demonstrated to
be the case in studies in foxes (24) and white-tailed deer (1). In
the fox study, blood samples were readily obtained from intact
carcasses stored for up to 11 days at 10°C, and sample degra-
dation was less if it was obtained postmortem from the thoracic
cavity rather than a blood vessel. These observations suggest
that samples obtained from the thoracic cavity postmortem are
particularly suitable for this application.
The median score for the condition of the blood from all
samples was 2 (range, 1 to 4, indicating best to worst condi-
tions). As we have previously found the hemolysis of badger
serum to significantly reduce the sensitivity of the BrockTB
Stat-Pak but not influence its specificity (2), we tested for any
significant difference between the median score of blood from
which a correct positive BrockTB Stat-Pak result was obtained
and the score from those samples giving a false-negative result
(Fig. 1). The median blood score for the true positive samples
was 3, and the score was 2 for the false-negative samples. This
difference was not statistically significant (P  0.49, Mann-
Whitney test).
In each badger, between 5 and 18 sites were examined for
lesions (mean, 15 sites). In some badgers it was not possible to
examine all sites due to traumatic damage to viscera or the
inability to locate all lymph nodes. Using carcass lesions as a
marker of infection was significantly less accurate (78%; 95%
CI, 74 to 82%) than the BrockTB Stat-Pak test (93%; 95% CI,
89 to 95%; P  0.0001, Fisher’s exact test), reflecting the fact
that other infections can produce visible lesions reminiscent of
bTB (12, 13). An example of this was evident in the current
study. One badger had an enlarged/lesioned popliteal lymph
node from which M. avium was subsequently isolated. This
badger was negative in the Stat-Pak test. Taking the sum of the
lesion scores in each tissue as a relatively crude indicator of the
severity of infection among M. bovis culture-positive badgers,
there was evidence that Stat-Pak positivity was associated with
more severe bTB, as reported previously (2). The median score
for the 13 Stat-Pak-positive badgers was 2 (range, 0 to 9), in
contrast to a score of 0 (range, 0 to 11) for the 24 Stat-Pak-
negative badgers. This difference was significant (P  0.05,
Mann-Whitney test).
The estimates of sensitivity and specificity were relative,
having been measured against culture on a limited range of
tissues. Gross examination of more tissues and obtainment of
more cultures from each badger would result in bTB being
detected in more carcasses (7). However, although culture may
miss M. bovis infection in some cases, it would be difficult to
replace this gold standard method with either the BrockTB
Stat-Pak test or postmortem examination alone.
Despite the relatively low sensitivity, the close association of
the BrockTB Stat-Pak test result with bTB status was highly
significant (P  0.0001, Fisher’s exact test), and the proportion
of seropositive animals that were infected divided by the pro-
portion of test-negative animals that were infected (relative
risk) was 11, compared with 3 for the application of visible
lesions (Table 1). Calculation of the odds ratio for the
BrockTB Stat-Pak test was 45 (95% CI, 14 to 149), which
means bTB positivity was 45 times more likely to be confirmed
in antibody-reactive animals than in the seronegative popula-
tion. This is in contrast to an odds ratio of 3 (95% CI, 2 to 6)
for the presence of visible lesions indicating bTB infection.
The PPV of the BrockTB Stat-Pak test was 76% (95% CI, 50
to 93%) and represented the percentage of badgers with a
positive test that were confirmed by culture to have bTB at the
prevalence of bTB represented by the 374 test samples (37/374;
10%). The bTB prevalence calculated from all animals submit-
ted to culture was 12% (55/459), so the subset used for
BrockTB Stat-Pak testing was representative of the whole. The
broad confidence intervals for the estimated test sensitivity and
PPV reflect the fact that only 17 seropositive results were
TABLE 1. Association between infection in badgers and result of blood test or presence of lesions
Test (no. tested)














Brock TB Stat-Pak (374) 24 13 35 4 333 99 11 0.0001
Presence of any lesion (453) 34 21 38 65 333 84 3 0.003
a As determined by positive culture confirmed by spoligotyping/VNTR (n  55) only. Six badgers with AFB present histologically but from which no positive culture
was obtained were discounted from the analysis as having ambiguous disease status.
b Proportion of test-positive animals that were infected divided by the proportion of test-negative animals that were infected.
FIG. 1. The influence of blood condition, scored from 1 (fresh with
little hemolysis) to 4 (severely hemolysed), on the Brock TB Stat-Pak
result for badgers confirmed as infected by culture only.
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obtained from a total of 379 badgers tested. Based on these
results, over three-quarters of BrockTB Stat-Pak test-reactive
badgers needn’t have been submitted to detailed postmortem
examination and culture in order to confirm their bTB status.
However, the PPV is dependent on both the properties of the
test and the population tested, because the lower the actual
disease prevalence, the lower the predictive value of the diag-
nostic test. Also, failure to attempt culture from a badger
would by definition mean a loss of molecular typing data, which
may be undesirable.
The ability of the BrockTB Stat-Pak test to detect bTB in
badgers and wild deer (20) using samples that we were able to
obtain from dead animals suggests that this may be a useful
approach generally applicable to other wildlife species. Given
its high specificity, low cost, ease of operation, and rapidity, the
BrockTB Stat-Pak test could be used to reduce the number of
badger carcasses submitted for examination, especially in sit-
uations where resources are limited, a prompt management
decision is needed, and/or investigation by the gold standard
method of culture is not possible. Accordingly, a positive
BrockTB Stat-Pak result would be accepted as a true positive,
while only animals negative by the test would be submitted to
more detailed postmortem examination and culture.
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